+1 416 736 2100 (ext. 33307)
© Copyright 2023 Global Strategy Labs. All rights Reserved.
Website by Office/Bureau.
August 13, 2024
“Analyzing antimicrobial resistance as a series of collective action problems” explores how antimicrobial resistance (AMR), a global health threat causing over 1.27 million deaths annually, presents at least nine distinct collective action problems.
On May 23rd, GSL’s AMR Policy Accelerator held a webinar exploring the need for unifying global targets and presenting the proposed 1-10-100 Unifying Global Targets developed by the Bellagio Group for Accelerating AMR Action. The 1-10-100 UGTs make an important contribution to discussions leading up to this year’s United Nations General Assembly (UNGA) High-level Meeting on […]
May 18, 2024
On May 16, 2024, Julia Bishop, Director of Strategy and Partnerships at the AMR Policy Accelerator, and Mathieu Poirier, Co-Director of the Global Strategy Lab, were among the attendees at the Multi-stakeholder Hearing on Antimicrobial Resistance.
February 27, 2024
Unpacking AMR launches with its first episode. Tune in to learn more about AMR and research initiatives aimed at supporting evidence-informed policymaking.
February 12, 2024
We are excited to announce that Global Strategy Lab at York University has been re-designated the World Health Organization (WHO) Collaborating Centre on Global Governance of Antimicrobial Resistance.
February 2, 2024
The new Globalisation and Health commentary propose that the introduction of an AMR protocol under Article 31 of the pandemic treaty could address three of the most complex AMR policy challenges that require sustained global collaboration.
January 24, 2024
Dr. Isaac Weldon, Investigator at the Global Strategy Lab, emphasizes the urgency of addressing AMR beyond a medical perspective.
In an interview with KCBS Radio, Dr. Isaac Weldon outlines 5 new principles to create institutions that can reduce AMR and achieve sustainable antimicrobial use for all.
January 9, 2024
New Global Strategy Lab (GSL) study introduces five new principles for creating institutions that can reduce drug resistance and increase our chances of achieving sustainable antimicrobial use for all.
November 24, 2023
The latest update to Rapid Scoping Review on COVID-19’s impact on AMU and AMR synthesis has just been published.